ALX Oncology Holdings Inc. (ALXO)
NASDAQ·Healthcare·Biotechnology
$1.64
+2.83%
Mkt Cap $86.22M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 27, 2026 | — | — | — | -$0.38 | -$0.42 | -10.53% | — | — |
| Q4 2025 Nov 7, 2025 | — | — | — | -$0.37 | -$0.41 | -10.81% | — | — |
| Q3 2025 Aug 12, 2025 | — | — | — | -$0.46 | -$0.49 | -6.52% | — | — |
| Q2 2025 May 8, 2025 | — | — | — | -$0.47 | -$0.58 | -23.40% | — | — |
| Q1 2025 Mar 6, 2025 | — | — | — | -$0.72 | -$0.55 | +23.61% | — | — |
| Q4 2024 Nov 7, 2024 | — | — | — | -$0.78 | -$0.58 | +25.64% | — | — |
| Q3 2024 Aug 8, 2024 | — | — | — | -$0.77 | -$0.76 | +1.30% | — | — |
| Q2 2024 May 9, 2024 | — | — | — | -$0.87 | -$0.71 | +18.39% | — | — |
| Q1 2024 Mar 7, 2024 | — | $2.48M | — | -$0.84 | -$0.93 | -10.71% | — | — |
| Q4 2023 Nov 13, 2023 | — | — | — | -$0.86 | -$1.24 | -44.19% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | -$0.85 | -$0.84 | +1.18% | — | — |
| Q2 2023 May 11, 2023 | — | — | — | -$0.84 | -$0.58 | +30.95% | — | — |
| Q1 2023 Mar 9, 2023 | — | — | — | -$0.91 | -$0.60 | +34.07% | — | — |
| Q4 2022 Nov 8, 2022 | — | — | — | -$0.75 | -$0.72 | +4.00% | — | — |
| Q3 2022 Aug 8, 2022 | — | — | — | -$0.66 | -$0.67 | -1.52% | — | — |
| Q2 2022 May 9, 2022 | — | — | — | -$0.77 | -$0.46 | +40.26% | — | — |
| Q1 2022 Feb 28, 2022 | — | — | — | -$0.63 | -$0.56 | +11.11% | — | — |
| Q4 2021 Nov 11, 2021 | — | — | — | -$0.47 | -$0.51 | -8.51% | — | — |
| Q3 2021 Aug 12, 2021 | — | — | — | -$0.42 | -$0.34 | +19.05% | — | — |
| Q2 2021 May 17, 2021 | — | — | — | -$0.46 | -$0.31 | +32.61% | — | — |